Skip to main content
82°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about LEGN
Recent news which mentions LEGN
< Previous
1
2
3
4
5
Next >
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
July 02, 2024
Tickers
JNJ
LEGN
NEWS
Tags
Briefs
LEGN
JNJ
From
Benzinga
Assessing Legend Biotech: Insights From 15 Financial Analysts
June 21, 2024
Tickers
LEGN
Tags
Benzinga
LEGN
BZI/AAR
From
Benzinga
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
June 17, 2024
Tickers
JNJ
LEGN
Tags
Analyst Ratings
Benzinga
Truist Securities
From
Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
June 09, 2024
Tickers
ACLS
AGIO
HALO
IRTC
Tags
HALO
News
NVAX
From
Benzinga
Unveiling 18 Analyst Insights On Legend Biotech
June 04, 2024
Tickers
LEGN
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
May 14, 2024
Tickers
LEGN
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024
May 13, 2024
Tickers
LEGN
Tags
Market News
Earnings Reports
LEGN
From
InvestorPlace
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
April 19, 2024
Tickers
BMY
GILD
JNJ
LEGN
Tags
Biotech
FDA
Stories That Matter
From
Benzinga
Analyst Ratings For Legend Biotech
April 17, 2024
Tickers
LEGN
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
Tickers
JNJ
LEGN
NEWS
NVS
Tags
Analyst Ratings
General
Benzinga
From
Benzinga
Unveiling 9 Analyst Insights On Legend Biotech
April 01, 2024
Tickers
LEGN
Tags
LEGN
Benzinga
Market News
From
Benzinga
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
March 20, 2024
Tickers
ASIA
BMY
JNJ
LEGN
Tags
NVS
BMY
LEGN
From
Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
March 18, 2024
Tickers
BMY
JNJ
LEGN
NEWS
Tags
Stories That Matter
FDA
Biotech
From
Benzinga
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
Tickers
BMY
JNJ
LEGN
NEWS
Tags
Stories That Matter
FDA
Biotech
From
Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
March 13, 2024
Tickers
BGNE
CLOV
HCM
LEGN
Tags
Benzinga
big gainers
MXCT
From
Benzinga
Earnings Scheduled For March 11, 2024
March 11, 2024
Tickers
ALTO
ASAN
ASRT
AVO
Tags
ASAN
CASY
OCUL
From
Benzinga
Earnings Preview: Legend Biotech
March 08, 2024
Tickers
LEGN
Tags
Market News
BZI/EP
Earnings
From
Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
March 07, 2024
Tickers
ACLX
BMY
GILD
JNJ
Tags
Health Care
ACLX
Analyst Color
From
Benzinga
What 4 Analyst Ratings Have To Say About Legend Biotech
March 07, 2024
Tickers
LEGN
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
Biotech
Stories That Matter
AZN
From
Benzinga
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
January 10, 2024
Tickers
ASIA
BABA
BGNE
CHIR
Tags
Market News
Markets
CHIR
From
Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
Tickers
ACLX
JNJ
LEGN
NEWS
Tags
General
Benzinga
Biotech
From
Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
December 29, 2023
Tickers
ALNY
ARWR
IBB
LEGN
Tags
Top Stories
ALNY
Benzinga
From
Benzinga
Key Takeaways From Legend Biotech Analyst Ratings
December 19, 2023
Tickers
LEGN
Tags
LEGN
Benzinga
Analyst Ratings
From
Benzinga
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
December 11, 2023
Tickers
ACLX
JNJ
LEGN
Tags
Benzinga
General
Analyst Ratings
From
Benzinga
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
November 20, 2023
Tickers
BMY
JNJ
LEGN
SPX
Tags
BMY
JNJ
LEGN
From
MarketWatch
Earnings Scheduled For November 20, 2023
November 20, 2023
Tickers
A
BLRX
BRBR
CENT
Tags
XELB
TCOM
FANH
From
Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Tickers
CVRX
JNJ
LEGN
NVS
Tags
Market News
LEGN
JNJ
From
Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
October 18, 2023
Tickers
JNJ
LEGN
Tags
Benzinga
Analyst Ratings
General
From
Benzinga
Analyst Ratings for Legend Biotech
October 18, 2023
Tickers
LEGN
Tags
Benzinga
LEGN
BZI/AAR
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
